<DOC>
	<DOCNO>NCT02933606</DOCNO>
	<brief_summary>This randomise , double-blind , placebo-controlled study , evaluate effect BNC210 versus placebo symptom Post-Traumatic Stress Disorder , measure Clinician-Administered PTSD Scale DSM-5 ( CAPS-5 ) . The secondary objective study evaluate effect BNC210 anxiety , depression , global functioning patient report outcomes patient PTSD . Safety tolerability BNC210 also assess . Study participant receive 12 week blind treatment follow 12 week follow-up period .</brief_summary>
	<brief_title>Phase II Study BNC210 PTSD</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>1 . Signed date informed consent . 2 . Male female 18 65 year age , inclusive . 3 . Diagnosed current PTSD define CAPS5 DSM5 . 4 . Currently use medication PTSD , except need ( PRN ) use benzodiazepine ( BZD ) frequency exceed 2 day per week 3 month prior Screening . The total dose must exceed 30 mg/day diazepam equivalent . 5 . Subjects currently receive psychotherapy except long term supportive counseling subject receive intensive regular psychotherapy minimum three month prior Screening . 6 . Females childbearing potential must negative serum pregnancy test Screening negative urine test Day 1 . Females childbearing potential must postmenopausal ( defined cessation regular menstrual period least 12 month prior Screening confirm follicle stimulate hormone ( FSH ) level menopausal range Screening ) . Two effective method contraception ( double barrier contraception hormonal contraceptive along barrier contraceptive ) must use study 16 week follow last study treatment . Contraception deem acceptable study include follow : Condoms Hormonal ( include oral , injected , intrauterine , transdermal , implant ) . Females must use hormonal contraceptive least 3 month prior randomization change contraceptive trial . Surgical sterilization ( i.e. , bilateral tubal ligation , bilateral oophorectomy , hysterectomy woman vasectomy men ) . Sterilized male patient must least 1 year postvasectomy consider nonchild bear potential . Rhythm method consider effective method birth control , however , abstinence may allow base opinion Investigator . Requirement contraception waive certain circumstance ( i.e . sex relationship ) approve Sponsor . Males must donate sperm least 16 week follow last study treatment . 7 . In opinion Investigator participant high probability adherence completion study , willing able withdraw refrain specific therapy . 8 . Fluent English able understand comply write verbal protocolrelated requirement . Exclusion Criteria 1 . Current ongoing exposure trauma cause PTSD . 2 . Failed three trial antidepressant medication ( ) prescribe treatment PTSD . Each trial must last least 6 week consider fail attempt . 3 . The use antidepressant medication ( SSRIs SNRIs ) within 2 week Screening . 4 . History significant traumatic brain injury . 5 . Depression measure MontgomeryÄsberg depression scale ( MADRS ) rating &gt; 23 . 6 . Bipolar psychotic disorder identify Screening use MINI ( V7.0 ) . 7 . A score ≥ 7 McLean Screening Instrument Borderline Personality Disorder ( MSIBPD ) Screening . 8 . History seizure disorder , uncontrolled sleep apnoea severe neurologic disease 9 . Increased risk suicide , define : Any previous suicide attempt disclose participant Screening use Columbia Suicide Severity Rating Scale ( CSSRS ) . Any active suicidal ideation suicidal behavior past year , capture Screening use CSSRS . A score &gt; 4 item 10 MADRS Screening . 10 . The use cytochrome P450 3A4 inducer within 30 day Screening . This include , limited : carbamazepine , phenytoin , oxcarbazepine , barbiturate , phenobarbital , butalbital , St. John 's wort , rifampicin , rifabutin , efavirenz , nevirapine , pioglitazone , troglitazone , corticosteroid systemic route , grapefruit grapefruitcontaining product . 11 . The use alprazolam flunitrazepam within 3 month Screening . 12 . History presence impair renal function , indicate clinically significant abnormal creatinine , blood urea nitrogen ( BUN ) , moderate severe renal dysfunction define CockcroftGault equation ( glomerular filtration rate ( GFR ) &lt; 50 mL/min ) . 13 . Liver disease liver injury indicate abnormal liver function test ( LFTs ) , aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , alkaline phosphatase ( ALP ) , serum bilirubin ( &gt; 2x upper limit normal [ ULN ] ) history hepatic cirrhosis . 14 . Any clinically significant abnormality laboratory test result Screening ( biochemistry , hematology urinalysis ) assess Investigator . 15 . Fridericiacorrected QT interval ( QTcF ) &gt; 460 msec male QTcF &gt; 480 msec female measure ECG Screening . 16 . Any clinically significant ECG abnormality determine Investigator Screening . 17 . A family history congenital long QT syndrome , Brugada syndrome unexplained sudden cardiac death . 18 . Positive result human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C ( HCV ) Screening . 19 . Moderate severe substance use alcohol dependence disorder identify DSM5 . 20 . Participation investigational study within 30 day Screening . 21 . Participants involve ongoing insurance workplace claim opinion Investigator likely impact mental health , presentation capacity patient engage study . 22 . Females pregnant , nursing , intend become pregnant study within 16 week last dose Investigational Product , males plan father/conceive child within 16 week last dose Investigational Product . 23 . Blood plasma donation significant blood loss within 60 day Day 1 . 24 . Known poor peripheral venous access . 25 . Subjects , opinion Investigator , suitable participate study due clinically significant finding medical history could interfere objective study put subject risk reason , investigator deems applicable . 26 . History allergy , allergic reaction hypersensitivity BNC210 excipients . 27 . BP systolic &gt; 160 mmHg diastolic &gt; 90 mmHg . Allow two repeat measure discretion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>